Article

Accommodating IOL encouraging for pseudophakic patients

The accommodating IOL (Crystalens, eyeonics) appears promising in providing pseudophakic patients with enough pseudoaccommodation to function without near glasses, said George I. Papastergiou, MD.

New Orleans-The accommodating IOL (Crystalens, eyeonics) appears promising in providing pseudophakic patients with enough pseudoaccommodation to function without near glasses, said George I. Papastergiou, MD.

He presented data from 83 eyes of 44 patients (ages 42 to 74 years old) who were followed for up to 3 years. At 2 weeks after surgery, all eyes showed excellent IOL centration, none had flare or cells in the anterior chamber, IOP was consistently

At last available follow-up, 100% of eyes had distance UCVA of 20/40 and 88% saw 20/25 or better, although nine eyes underwent LASIK for >1 D of residual myopia.

Near UCVA was J4 or better in 100% of eyes and J3 or better in 93.8%, and all eyes could read J4 or better through distance correction. Accommodative range by defocusing was between 0.75 and 2.0 D and appeared stable throughout the study, averaging 1.65 D at 1 month and 1.48 D at 36 months.

Dr. Papastergiou reported 23 eyes required Nd:YAG capsulotomy. While they initially presented with regression of the accommodative effect, they improved following the capsulotomy with a mean change of 0.22 D.

"We have found high patient satisfaction in this group, although we caution surgeons to be careful in selecting candidates. Since the optic is only 4.5 mm, we implant this accommodating IOL only in eyes with a scotopic pupil

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.